Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.
about
Alogliptin benzoate for management of type 2 diabetesIdentifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetesAsian Americans have greater prevalence of metabolic syndrome despite lower body mass indexDevelopment of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes. Genetic reconstitution of diabetes as a polygenic diseaseIdentification of differential responses to an oral glucose tolerance test in healthy adultsUndiagnosed Diabetes and Pre-Diabetes in Health Disparities.Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care.Insulin secretion and computed tomography values of the pancreas in the early stage of the development of diabetesPlasma glucose concentration and prediction of future risk of type 2 diabetes.Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents.Deterioration of insulin sensitivity and beta-cell function in overweight Hispanic children during pubertal transition: a longitudinal assessment.Influence of waist on adiponectin and insulin sensitivity in adolescence.Insights into insulin resistance and type 2 diabetes from knockout mouse models.Increase in homeostasis model assessment of insulin resistance (HOMA-IR) had a strong impact on the development of type 2 diabetes in Japanese individuals with impaired insulin secretion: the Saku study.The OGTT as test for beta cell function?Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes.Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trialβ-cell function is associated with metabolic syndrome in Mexican subjects.The evaluation of metabolic function and fat redistribution in clinical trials.Chinese herbal medicine for impaired glucose tolerance: a randomized placebo controlled trialDeletion of hypoxia-inducible factor-1α in adipocytes enhances glucagon-like peptide-1 secretion and reduces adipose tissue inflammationInvestigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index?Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention StudyRacial/Ethnic Differences in Insulin Resistance and Beta Cell Function: Relationship to Racial Disparities in Type 2 Diabetes among African Americans versus Caucasians.Insulin resistance and excess risk of diabetes in Mexican-Americans: the San Antonio Heart StudyGlucose response curve and type 2 diabetes risk in Latino adolescentsFasting insulin levels and metabolic risk factors in type 2 diabetic patients at the first visit in Japan: a 10-year, nationwide, observational study (JDDM 28)Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: the IRAS Family StudyAcute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations.Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test.Impact of differences in glucose tolerance on the prevalence of a negative insulinogenic index.Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesPersistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat.Persistence of the metabolic syndrome over 3 annual visits in overweight Hispanic children: association with progressive risk for type 2 diabetesIn vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusComparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans
P2860
Q28083933-E7CB0B21-EB62-4B10-AF7F-389C8B23FAA0Q28218908-AEACE55E-F865-4627-B180-A120D2E49453Q28384740-4970650E-BD3C-498E-A918-2F5E496C621CQ28510789-8F697FAB-8973-4448-9314-0A197E3015F0Q28535572-6AE629BE-4760-4E0B-A984-788B5EA6EE56Q30376841-8E3E7467-3CCF-4258-97D0-97FC9C1B2DA2Q33556828-C1D2D492-5962-475E-9FF1-816EFEB83904Q33603352-F4623D1F-5710-43D5-905A-12437AE4D3C9Q33610774-A4D00C78-B203-4112-BA35-037C9437DA43Q33705489-203F6169-F663-436C-8CE5-1F39D82C16FDQ33720356-D9D1CDED-EDBC-4C97-B95D-D2ACD38A2AF4Q33822103-801D717A-4CC8-4108-9812-99213C6FD394Q34011039-EFD2CFD1-9325-4E76-A0A2-D14F68267399Q34105100-690B609F-E5BD-45D3-9313-86CE3341C50FQ34266395-43C617E0-F8C1-4E40-86EC-353F6CEE8623Q34292429-56D142D7-5356-4346-990E-DC33707E9D28Q34424907-00435FBE-FA5D-4CD4-85AB-48FDC9F64FC2Q34503601-32B439FD-1C8D-41D1-9B02-EB4FFAB3CD91Q34527061-9137F134-D194-4925-AA8D-26BB59601887Q34620434-49FC181A-18F1-43C8-A424-7F7E338AD5FFQ34680620-65C47AD2-7340-47A2-9F5F-B8EF0110DAABQ34721973-99ED11AD-4A73-4F5C-96A8-75468D4ED966Q35140330-388C5AE0-D8B8-4482-B6F3-A33F60D2A957Q35143536-0F2BCDAF-AE28-411E-AB79-6EF04495396FQ35688277-94E1D048-01A2-4AB0-A6BC-6701083A7641Q35857908-8560C690-1D6A-4BE6-B2C3-D38BF02F7464Q35869619-641627C2-C005-4150-8623-944033B6A9F9Q36181336-57F2DAD8-FAC6-438A-9BA3-6D77DCC9AA17Q36181424-19723D27-96CD-407F-9425-97B759C066B2Q36201564-86316395-510E-413D-BE2B-81A191846301Q36248046-B6D871A4-C570-4946-9D97-32B6FD8030B9Q36320560-40D66786-1D4C-4654-AEEB-C980F3C862C2Q36677585-148C7617-2926-44D3-BBB6-4FF2994400BFQ36745280-C5C9045A-FD4A-4876-895D-9D1D316DA67DQ36839519-C1FF1BA6-D69A-4771-8CEE-4613D1C771DDQ36943732-D1EBEBAF-C8B9-4093-A642-428BFF259FDDQ37007558-90944436-31FB-42F8-8D86-D44419BE73A1Q37022913-201B2E8F-BB81-4A69-8F08-1FC5977B459BQ37141727-73622196-DA6E-494E-8E95-0FA0AF8476B1Q37198163-9BE56CF4-8AA4-4EA9-92B8-B984FA56450E
P2860
Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Decreased insulin secretion an ...... of NIDDM in Mexican-Americans.
@en
Decreased insulin secretion an ...... of NIDDM in Mexican-Americans.
@nl
type
label
Decreased insulin secretion an ...... of NIDDM in Mexican-Americans.
@en
Decreased insulin secretion an ...... of NIDDM in Mexican-Americans.
@nl
prefLabel
Decreased insulin secretion an ...... of NIDDM in Mexican-Americans.
@en
Decreased insulin secretion an ...... of NIDDM in Mexican-Americans.
@nl
P2093
P356
P1433
P1476
Decreased insulin secretion an ...... of NIDDM in Mexican-Americans.
@en
P2093
Gaskill SP
Haffner SM
Miettinen H
P304
P356
10.2337/DIAB.44.12.1386
P407
P577
1995-12-01T00:00:00Z